Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/15/1989 | EP0341444A2 Rapid mutational analysis method |
11/15/1989 | EP0341304A1 Improved ricin molecules and ricin toxin conjugates |
11/15/1989 | EP0341303A1 Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells |
11/15/1989 | EP0341290A1 Immunoglobulin e competitor |
11/15/1989 | EP0341287A1 Diagnostic methods and systems for quantifying apo ai |
11/15/1989 | EP0341273A1 Biological materials, processes for producing biological materials and for using such materials in therapy |
11/15/1989 | EP0341252A1 Human polymorphic epithelial mucin polypeptides for use in therapy and diagnosis |
11/15/1989 | EP0335528A2 DNA promoter fragments from wheat |
11/15/1989 | EP0165313B1 Nucleic acid hybridization assay |
11/15/1989 | CN1037174A Novel revombinant and chimeric antibodies directed against human adenocarcinoma |
11/15/1989 | CN1037173A Bone inducing protein |
11/14/1989 | US4880915 Tumor necrosis factor; dye ligand covalently bound to crosslinked agarose |
11/14/1989 | US4880911 Urogastrone, interferons |
11/14/1989 | US4880910 Polypeptides, milk production |
11/14/1989 | US4880746 Vectors, dna |
11/14/1989 | US4880744 Acidic medium, rice |
11/14/1989 | US4880741 Dna, marking |
11/14/1989 | US4880734 Eukaryotic regulatable transcription |
11/14/1989 | CA1262877A1 Expression vector of factor ix and cell line producing the active factor ix |
11/14/1989 | CA1262863A1 Fusogenic liposomes and method of making same |
11/08/1989 | EP0341215A2 Improvements in the production of polypeptides |
11/08/1989 | EP0341100A2 DNA coding for thymosin and TNF |
11/08/1989 | EP0340986A2 High level expression of proteins in yeast |
11/08/1989 | EP0340948A1 Novel hybrid pesticidal toxins |
11/08/1989 | EP0340837A1 Recombinant GAG precursor of HIV, product, process, and use as aids vaccine |
11/08/1989 | EP0340806A2 Synthesis of human virus antigens by yeast |
11/08/1989 | EP0340805A1 Superoxide dismutase and expression in microorganisms |
11/08/1989 | EP0340609A2 Device for the isolation of nucleic acids |
11/08/1989 | EP0340359A1 Baculovirus transfer vectors |
11/08/1989 | EP0340333A2 Novel physiologically active polypeptide and pharmaceutical composition |
11/08/1989 | CN1036987A Human c3b/c4b receptor (cr1) |
11/07/1989 | US4879374 Genetic vectors, genetic engineering |
11/07/1989 | US4879241 Cloning vectors, genetic engineering |
11/07/1989 | US4879236 Genetic engineering, baculovirus |
11/07/1989 | US4879231 Transformation of yeasts of the genus pichia |
11/07/1989 | US4879230 Escherichia coli Candida maltosa Saccharomyces cerevisiae shuttle vectors and method for making |
11/07/1989 | US4879227 Gene expression of protein |
11/07/1989 | US4879226 Novel human physiologically active polypeptide |
11/07/1989 | US4879225 Enhanced production of antibodies utilizing insolubilized immune complexes |
11/07/1989 | US4879224 DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides |
11/07/1989 | US4879219 Immunoassay utilizing monoclonal high affinity IgM antibodies |
11/07/1989 | US4879217 Monoclonal antibodies for immunoassay |
11/07/1989 | EP0270615A4 TRANSFORMATION AND FOREIGN GENE EXPRESSION IN -i(BRASSICA) SPECIES. |
11/07/1989 | CA1262799A1 Broad spectrum vaccine against gonorrhea |
11/07/1989 | CA1262696A1 Process for the microbiological preparation of the human serum-albumin |
11/07/1989 | CA1262695A1 Process for the microbiological preparation of the human serum-albumin |
11/07/1989 | CA1262694A1 Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria |
11/02/1989 | WO1989010565A1 Detection, quantitation and classification of ras proteins in body fluids and tissues |
11/02/1989 | WO1989010413A1 Replicatable hybridizable recombinant rna probes and methods of using same |
11/02/1989 | WO1989010412A1 Detection of neu gene expression and products |
11/02/1989 | WO1989010409A1 Bone and cartilage inductive compositions |
11/02/1989 | WO1989010408A1 Method of obtaining l-alanine |
11/02/1989 | WO1989010407A1 Homogeneous dimeric m-csf and storage stable formulations thereof |
11/02/1989 | WO1989010406A1 Bovine placental lactogen gene |
11/02/1989 | WO1989010405A1 Chimeric glycoproteins containig immunogenic segments of human parainfluenza virus type 3 |
11/02/1989 | WO1989010404A1 Recombinant dna methods, vectors and host cells |
11/02/1989 | WO1989010403A1 Human gm-csf variants |
11/02/1989 | WO1989010402A1 Low molecular weight derivatives of prourokinase and pharmaceutical compositions containing the same |
11/02/1989 | WO1989010401A1 Plasminogene activators with increased fibrin selectivity |
11/02/1989 | WO1989010396A1 Plants with modified stamen cells |
11/02/1989 | WO1989010376A1 Monoclonal antibody for colorectal carcinoma |
11/02/1989 | WO1989010375A1 Monoclonal antibodies specific for the harvey, kirsten and n ras proteins and their use as diagnostic reagents |
11/02/1989 | WO1989010374A1 Aprotinin analogues and a process for the production thereof |
11/02/1989 | WO1989010137A1 Vaccine derived from bacteria of the genus yersinia |
11/02/1989 | WO1989010133A1 Stem cell inhibitors |
11/02/1989 | WO1989007651A3 Methods for controlling norleucine content in polypeptides |
11/02/1989 | EP0340197A2 Insect-resistant lettuce plants |
11/02/1989 | EP0340170A2 Process for the production of polypeptides |
11/02/1989 | EP0340109A2 Anti-T-cell receptor determinants as autoimmune disease treatment |
11/02/1989 | EP0339942A2 Aprotinin analogues and process for the production thereof |
11/02/1989 | EP0339830A2 Improved biological nitrogen fixation |
11/02/1989 | EP0339814A1 Reagent for measuring creatine kinase activity and measuring method thereof |
11/02/1989 | EP0339783A2 Detection of yersinia enterocolitica using nucleic acid probes |
11/02/1989 | EP0339686A1 Nucleic acid hybridization assay |
11/02/1989 | EP0339633A2 Anti-human gastric cancer monoclonal antibody |
11/02/1989 | EP0339632A2 Method of assaying human cancer antigens |
11/02/1989 | EP0339569A2 Expression of the HIV 24 KDA GAG protein in methylotrophic yeasts |
11/02/1989 | EP0339567A1 Expression of Hepatitis B PreS 2 Protein in Methylotrophic Yeasts |
11/02/1989 | EP0339532A1 DNA strand coding for alpha-acetolactate decarboxylase and yeast transformed with the DNA strand |
11/02/1989 | EP0339443A2 Monoclonal antibody for the selective immune determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids |
11/02/1989 | EP0339389A1 Test device |
11/02/1989 | EP0339285A2 Recombinant endonexin II |
11/02/1989 | EP0339163A2 Monoclonal antibodies specific for HIV and hybridomas for their production |
11/02/1989 | DE3909249A1 DNA with genetic information of glutamine synthetase and use thereof |
11/02/1989 | DE3744038A1 Human manganese superoxide dismutase (hMn-SOD) |
11/01/1989 | CN1036793A Monoclonal antibody specific to mucin-like glycoprotein surface antigen on human carcinoma cells |
10/31/1989 | US4877865 Bovine interferon |
10/31/1989 | US4877864 Osteoinductive factors |
10/31/1989 | US4877737 Attenuated pseudorabies virus which has a deletion in at least a portion of a repeat sequence and vaccine containing same |
10/31/1989 | CA1262533A1 High level production of swine growth hormone |
10/31/1989 | CA1262532A1 Composition useful for the production of vaccines containing particles with the surface antigen of the hepatitis b virus and the receptor of the polymerized human serum albumin, animal cells capable of producing such particles and process for their obtention |
10/25/1989 | EP0339009A2 Method for improving the efficacy of insect toxins |
10/25/1989 | EP0338841A1 Recombinant DNA methods, vectors and host cells |
10/25/1989 | EP0338807A2 Production of isolated proteinaceous materials using recombinant avipox virus vectors |
10/25/1989 | EP0338790A2 Production of homoserine and its derivatives such as threonine derivatives and methionine precursors |
10/25/1989 | EP0338767A2 Novel recombinant and chimeric antibodies directed against a human adenocarcinoma antigen |
10/25/1989 | EP0338745A1 Method for producing recombinant DNA proteins |
10/25/1989 | EP0338690A1 Regulation of gene expression |
10/25/1989 | EP0338634A2 Viper venom polypeptides and genetic expression |
10/25/1989 | EP0338620A1 Recovery of hepatitis B surface antigen |